bioRxiv Science⌕ Search

Biology subjects

Lopez-Anido, C.

Publications and source records attributed to Lopez-Anido, C..

2 recordsLinked to original sources

Integration of Nuclear Receptors into a Schwann cell Gene Regulatory Network

Peripheral nerve function depends on the proper formation and maintenance of Schwann cells. During development, large diameter axons are enveloped by single, myelinating Schwann cells whereas clusters of small diameter axons are surrounded by nonmyelinating Schwann cells in Remak bundles. The transcription factor SRY-box 10 (SOX10) is required for the development of Schwann cells, but its functions in different neural crest and glial lineages have shown that SOX10 commonly cooperates with other transcription factors to activate cell-specific gene programs. In a previous study, we compared SOX10-bound regulatory elements in Schwann cells and identified a specific enrichment for nuclear receptor motifs at SOX10 binding sites in Schwann cells. NR2F1 and NR2F2 (Coup-TFI/Coup-TFII) are expressed from neural crest through Schwann cell maturity, and knockdown of nuclear receptors Nr2f1 and Nr2f2 in primary Schwann cells downregulated several myelin genes. In this study, we have identified a NR2F-regulated target gene network in Schwann cells, which revealed enrichment for nonmyelinating Schwann cell genes. Cut&Run assays in S16 Schwann cells revealed novel, genome-wide binding sites of NR2F2 and two downstream transcription factors: 1) Retinoid X Receptor Gamma (RXRG), which is also expressed preferentially in nonmyelinating Schwann cells, and 2) TEA-Domain factor (TEAD1), which is an important HIPPO pathway component required for Remak bundle formation. Our study elucidates the transcriptional cooperation that programs the regulatory network in nonmyelinating Schwann cells.

neuroscience↗

Neuregulin 1 type III reduces severity in a mouse model of Congenital Hypomyelinating Neuropathy

Myelin sheath thickness is precisely regulated and essential for rapid propagation of action potentials along myelinated axons. In the peripheral nervous system, extrinsic signals from the axonal protein neuregulin 1 type III regulate Schwann cell fate and myelination. Here we ask if modulating neuregulin 1 type III levels in neurons would restore myelination in a model of congenital hypomyelinating neuropathy (CHN). Using a mouse model of CHN, we rescued the myelination defects by early overexpression of neuregulin 1 type III. Surprisingly, the rescue was independent from the upregulation of Egr2 or essential myelin genes. Rather, we observed the activation of MAPK/ERK and other myelin genes such as peripheral myelin protein 2 (Pmp2) and oligodendrocyte myelin glycoprotein (Omg). We also confirmed that the permanent activation of MAPK/ERK in Schwann cells has detrimental effects on myelination. Our findings demonstrate that the modulation of axon-to-glial neuregulin 1 type III signaling has beneficial effects and restores myelination defects during development in a model of CHN.\n\n\n\nO_TBL View this table:\norg.highwire.dtl.DTLVardef@103281aorg.highwire.dtl.DTLVardef@3dc68eorg.highwire.dtl.DTLVardef@1b6c5feorg.highwire.dtl.DTLVardef@80e419org.highwire.dtl.DTLVardef@1ff2591_HPS_FORMAT_FIGEXP M_TBL C_TBL

neuroscience↗